SOD-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of SOD-1 monoclonal antibodies for advanced research in oxidative stress and neurodegenerative diseases. SOD-1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Superoxide dismutase 1 (SOD-1) protects cells from oxidative damage by catalyzing the dismutation of superoxide radicals into oxygen and hydrogen peroxide. SOD-1 has significant implications in neurodegenerative disorders, particularly in amyotrophic lateral sclerosis (ALS), where SOD-1 gene mutations contribute to disease progression. Understanding SOD-1 function and regulation is crucial for developing therapeutic strategies to combat oxidative stress-related cellular damage. Researchers can explore oxidative stress mechanisms using SOD-1 monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC). Investigating SOD-1 activity patterns helps reveal its role in cellular defense mechanisms and potential therapeutic targets. Current research focusing on SOD-1 continues to uncover new aspects of its involvement in neurodegenerative processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of oxidative stress and neurodegenerative diseases.